DDAH1 antibody (C-Term)
Quick Overview for DDAH1 antibody (C-Term) (ABIN452906)
Target
See all DDAH1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- This antibody detects DDAH1 at C-term.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human, Mouse
-
Purification
- Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogen
- KLH conjugated synthetic peptide selected from the C-terminal region of human DDAH1
-
-
-
-
Application Notes
-
Western blot: 1: 50 - 1: 100. ELISA: 1: 1,000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- DDAH1 (Dimethylarginine Dimethylaminohydrolase 1 (DDAH1))
-
Alternative Name
- DDAH1
-
Background
- DDAH1 plays a role in nitric oxide generation by regulating cellular concentrations of methylarginines, which in turn inhibit nitric oxide synthase activity.Synonyms: DDAH, DDAH-1, DDAHI, Dimethylargininase-1, Dimethylarginine dimethylaminohydrolase 1, N(G), N(G)-dimethylarginine dimethylaminohydrolase 1
-
Molecular Weight
- 31122 Da
-
Gene ID
- 23576
-
NCBI Accession
- NP_036269
-
UniProt
- O94760
Target
-